Literature DB >> 18836135

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Deepak L Bhatt, James Scheiman, Neena S Abraham, Elliott M Antman, Francis K L Chan, Curt D Furberg, David A Johnson, Kenneth W Mahaffey, Eamonn M Quigley.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18836135     DOI： 10.1161/CIRCULATIONAHA.108.191087

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  107 in total

1.  Endoscopy Is Relatively Safe in Patients with Acute Ischemic Stroke and Gastrointestinal Hemorrhage.

Authors:  Mohamed Tausif Siddiqui; Mohammad Bilal; Lakshmi Asritha Gollapudi; Dhruv Mehta; Shifa Umar; Jonathan Barsa; Christopher Nabors; Beth Schorr-Lesnick; Edward Lebovics; Virendra Tewari
Journal:  Dig Dis Sci       Date:  2018-12-05       Impact factor: 3.199

Review 2.  Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John W Eikelboom; Jack Hirsh; Frederick A Spencer; Trevor P Baglin; Jeffrey I Weitz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Clopidogrel and proton pump inhibitors: a new drug interaction?

Authors:  Doson Chua; Jennifer Bolt; Angela Lo; Anita Lo
Journal:  Can J Hosp Pharm       Date:  2010-01

4.  Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.

Authors:  Chen-Fang Lin; Li-Jiuan Shen; Fe-Lin Lin Wu; Chyi-Huey Bai; Churn-Shiouh Gau
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

Review 5.  The clinical relevance of the clopidogrel-proton pump inhibitor interaction.

Authors:  Atif Mohammad; Emmanouil S Brilakis; Rick A Weideman; Bertis B Little; Subhash Banerjee
Journal:  J Cardiovasc Transl Res       Date:  2012-02-14       Impact factor: 4.132

6.  Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention.

Authors:  Atsuko Nakayama; Hiroyuki Morita; Jiro Ando; Hideo Fujita; Hiroshi Ohtsu; Ryozo Nagai
Journal:  Heart Vessels       Date:  2012-03-30       Impact factor: 2.037

7.  Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes.

Authors:  Takahisa Furuta; Takayuki Iwaki; Kazuo Umemura
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

8.  Collagenous Colitis Associated with Rabeprazole in a Peritoneal Dialysis Patient.

Authors:  Masaru Murasawa; Tsutomu Sakurada; Daisuke Oishi; Tomo Suzuki; Naoto Tominaga; Hiroo Kawarazaki; Sayuri Shirai; Yugo Shibagaki; Kenjiro Kimura
Journal:  Perit Dial Int       Date:  2015 Sep-Oct       Impact factor: 1.756

9.  Utility of Physiologically Based Pharmacokinetic Absorption Modeling to Predict the Impact of Salt-to-Base Conversion on Prasugrel HCl Product Bioequivalence in the Presence of Proton Pump Inhibitors.

Authors:  Jianghong Fan; Xinyuan Zhang; Liang Zhao
Journal:  AAPS J       Date:  2017-07-14       Impact factor: 4.009

10.  A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Authors:  David N Juurlink; Tara Gomes; Dennis T Ko; Paul E Szmitko; Peter C Austin; Jack V Tu; David A Henry; Alex Kopp; Muhammad M Mamdani
Journal:  CMAJ       Date:  2009-01-28       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.